Most monkeypox stocks rose, with Virax Biolabs (VRAX.US) rising nearly 190%.

As of the time of writing, most of the monkeypox stocks rose on Monday. Virax Biolabs (VRAX.US) rose nearly 190%, Applied DNA Sciences (APDN.US) rose nearly 130%, Tonix Pharmaceuticals (TNXP.US) rose nearly 50%, Geovax Labs (GOVX.US) rose more than 29%, Co-Diagnostic (CDOX.US) rose nearly 18%, Chimerix (CMRX.US) rose 0.02%; Siga Technologies (SIGA.US) fell more than 5.8%, Emergent Biosolutions (EBS.US) fell more than 1.2%. On Monday, the Philippine Department of Health announced the country's first case of the monkeypox virus since December last year, after the latest cases were reported in Sweden and Pakistan.

The number of suspected or confirmed monkeypox cases reported in Africa this year has surpassed the total number of cases reported in the whole of last year. The WHO Director-General declared the monkeypox outbreak a public health emergency of international concern on August 14, and the monkeypox stocks have been rising since then.